Incidence of intussusception in Singaporean children aged less than 2 years: a hospital-based prospective study

BMC Pediatrics

Yanfang Liu⁴  Kusuma Gopala¹  Kumaran Vadivelu-Pechai⁴  Harvey Teo²  Anette Jacobsen²  Seng Hock Quak⁵  Bee-Wah Lee³  Kong Boo Phua² 

[1] GlaxoSmithKline Pharmaceuticals, Bangalore, India;KK Women’s and Children’s Hospital, Singapore, Singapore;Mount Elizabeth Hospital, Singapore, Singapore;GlaxoSmithKline Vaccines, Singapore, Singapore;National University Hospital, Singapore, Singapore

关键词: Rotavirus vaccine;    Surveillance;    Hospital-based;    Singapore;    Intussusception;   

Others  :  1144447
DOI  :  10.1186/1471-2431-13-161

 received in 2012-10-18, accepted in 2013-07-16,  发布年份 2013

【 摘 要 】

Background

Continuous surveillance for intussusception (IS) is important for monitoring the safety of second-generation rotavirus vaccines. The present study aimed to assess the incidence of IS in Singaporean children aged < 2 years.

Methods

This was a prospective, hospital-based, multi-center surveillance conducted in seven hospitals - two public hospitals and five private medical centers between May 2002 and June 2010 in Singapore. Diagnosis of IS (definite, probable, possible, suspected) was based on the case definition developed by the Brighton Collaboration. Children < 2 years of age who were diagnosed with IS were enrolled in this study. Incidence of IS was calculated per 100,000 child-year with its 95% confidence interval.

Results

Of the 178 children enrolled, 167 children with definite IS cases were considered for final analyses; 11 were excluded (six diagnosed as probable IS and four diagnosed as suspected IS; one child’s parents withdrew consent). Mean age of children with definite IS was 11.6 ± 6 months; 67.7% were males. The overall incidence of IS was 28.9 (95% CI: 23.0–34.8) and 26.1 (95% CI: 22.2–30.0) per 100,000 child-year in children < 1 year and < 2 years of age, respectively. The majority of IS cases (20 [12.0%]) were reported in children aged 6 months. Most children (98.2% [164/167]) recovered, two (1.2%) children recovered with sequelae and one (0.6%) child died of septic shock.

Conclusions

The incidence of IS remained low and stable in Singaporean children aged < 2 years during the study period (May 2002 to June 2010).

Trial registration

NCT01177839

【 授权许可】

   
2013 Phua et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Stringer MD, Pablot SM, Brereton RJ: Paediatric intussusception. Br J Surg 1992, 79:867-876.
• [2]Bines J, Ivanoff B: Acute Intussusception in Infants and Children: Incidence, Clinical Presentation and Management: A Global Perspective. Geneva, Switzerland: World Health Organization; 2002.
• [3]Bines JE, Liem NT, Justice F, Son TN, Carlin JB, de Campo M, Jamsen K, Mulholland K, Barnett P, Barnes GL: Validation of clinical case definition of acute intussusception in infants in Viet Nam and Australia. Bull World Health Organ 2006, 84(7):569-575.
• [4]Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network, et al.: 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(2):136-141.
• [5]Robinson CG, Hernanz-Schulman M, Zhu Y, Griffin MR, Gruber W, Edwards KM: Evaluation of anatomic changes in young children with natural rotavirus infection: is intussusception biologically plausible? J Infect Dis 2004, 189:1382-1387.
• [6]Chang EJ, Zangwill KM, Lee H, Ward JI: Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 2002, 21(2):97-102.
• [7]Chouikha A, Fodha I, Maazoun K, Ben Brahim M, Hidouri S, Nouri A, Trabelsi A, Steele AD: Rotavirus infection and intussusception in Tunisian children: implications for use of attenuated rotavirus vaccines. J Pediatr Surg 2009, 44(11):2133-2138.
• [8]Bahl R, Saxena M, Bhandari N, Taneja S, Mathur M, Parashar UD, Gentsch J, Shieh WJ, Zaki SR, Glass R, Bhan MK, for the Delhi Intussusception Study Hospital Group: Population-based incidence of intussusception and a case–control study to examine the association of intussusception with natural rotavirus infection among Indian children. J Infect Dis 2009, 200(1):277-281.
• [9]Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okaro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livinghood JR, for the Rotavirus Intussusception Investigation Team: Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001, 344:564-572. Erratum in: N Engl J Med 2001, 344:1564
• [10]Center for Disease Control and Prevention: Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999, 8:1007.
• [11]Murphy TV, Smith PJ, Gargiullo PM, Schwartz B: The first rotavirus vaccine and intussusception: Epidemiological studies and policy decisions. J Infect Dis 2003, 187(8):1309-1313.
• [12]Glass RI, Bresee JS, Parashar UD, Jiang B, Gentsch J: The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 2004, 363(9420):1547-1550.
• [13]Tan N, Teoh YL, Phua KB, Quak SH, Lee BW, Teo HJ, Jacobson A, Boudville IC, Ng T, Verstraeten T, Bock HL: An update of Paediatric Intussusception in Singapore: 1997–2007, 11 years of Intussusception surveillance. Ann Acad Med 2009, 38(8):690-292.
• [14]Palacios GMR, Schael IP, Velasquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivere-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nunez E, Geurrero L, Yarzábal JP, Damaso S, Tornieporth N, Liorens XS, for the Human Rotavirus Vaccine Study Group, et al.: Safety and efficacy of an attenuated vaccine against severe Rotavirus gastroenteritis. N Engl J Med 2006, 351:11-22.
• [15]Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, for the Rotavirus Efficacy and Safety Trial Study Team: Safety and Efficacy of a Pentavalent Human-Bovine (WC3) reassortant Rotavirus Vaccine. N Engl J Med 2006, 354:22-23.
• [16]Velázquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, Breuer T, Verstraeten T: Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012, 31(7):736-744.
• [17]Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE: Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011, 29(16):3061-3066.
• [18]Greenberg HB: Rotavirus Vaccination and Intussusception-Act Two. N Engl J Med 2011, 364:2354-2355.
• [19]Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM: Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clin Infect Dis 2012, 54(10):1397-1405.
• [20]Boudville IC, Phua KB, Quak SH, Lee BW, Han HH, Verstraeten T, Bock HL: The epidemiology of paediatric intussusception in Singapore: 1997 to 2004. Ann Acad Med Singapore 2006, 35(10):674-679.
• [21]Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, Murphy TM, Music S, Niu M, Varricchio F, Vermeer P, Wong EJ: Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004, 22:569-574.
• [22]Chen SCC, Wang JD, Hsu HY, Leong MM, Tok TS, Chin YY: Epidemiology of childhood intussusception and determinants of recurrence and operation: Analysis of National Health Insurance data between 1998 and 2007 in Taiwan. Pediatr Neonatol 2010, 51(5):285-291.
• [23]Bissantz N, Jenke AC, Trampisch M, Klaassen-Mielke R, Bissantz K, Trampiscj HJ, Holland-Letz T: Hospital-based, prospective, multicentre surveillance to determine the incidence of intussusception in children aged below 15 years in Germany. BMC Gastroenterol 2011, 11:26. BioMed Central Full Text
• [24]Jo DS, Nyambat B, Kim JS, Jang YT, Ng TL, Bock HL, Kilgore PE: Population-based incidence and burden of childhood intussusception in Jeonbuk Province, South Korea. Int J Infect Dis 2009, 13:e383-388.
• [25]Khumjuia C, Doung-ngerna P, Sermgewb T, Smitsuwan P, Jiraphongsa C: Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006. Vaccine 2009, 27(Suppl 5):F116-119.
• [26]Justice F, Carlin J, Bines J: Changing epidemiology of intussusception in Australia. J Paediatr Child Health 2005, 41:475-478.
• [27]Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, Glass RI: Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics 2000, 106:1413-1421.